| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.49B | 3.87B | 4.69B | 3.58B | 3.89B | 3.23B |
| Gross Profit | 1.93B | 1.84B | 2.17B | 1.74B | 2.25B | 1.58B |
| EBITDA | 3.32B | 3.09B | 3.40B | 2.57B | 2.94B | 2.28B |
| Net Income | 703.61M | 656.78M | 765.31M | 453.11M | 1.46B | 160.49M |
Balance Sheet | ||||||
| Total Assets | 37.38B | 37.51B | 36.50B | 36.34B | 35.66B | 36.37B |
| Cash, Cash Equivalents and Short-Term Investments | 2.17B | 1.98B | 2.38B | 2.48B | 2.92B | 1.52B |
| Total Debt | 17.09B | 17.49B | 17.08B | 17.76B | 16.71B | 17.73B |
| Total Liabilities | 21.63B | 22.10B | 21.65B | 22.10B | 21.19B | 22.71B |
| Stockholders Equity | 12.01B | 11.85B | 11.61B | 11.23B | 11.51B | 10.42B |
Cash Flow | ||||||
| Free Cash Flow | 2.90B | 2.63B | 2.77B | 2.19B | 2.55B | 2.09B |
| Operating Cash Flow | 2.92B | 2.66B | 2.80B | 2.21B | 2.57B | 2.10B |
| Investing Cash Flow | -1.47B | -1.30B | -1.16B | -668.38M | 1.29B | -238.53M |
| Financing Cash Flow | -1.87B | -1.76B | -1.73B | -1.98B | -2.45B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$6.73B | 13.69 | 5.90% | 5.26% | 7.04% | 7.64% | |
69 Neutral | HK$28.56B | 10.82 | 15.46% | 5.08% | 5.50% | 11.50% | |
64 Neutral | HK$63.07B | 9.84 | 11.38% | 5.43% | 25.01% | 3.40% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$25.37B | -12.81 | 5.00% | 3.72% | 7.13% | -52.33% | |
52 Neutral | HK$18.83B | 14.25 | 8.39% | 5.82% | -20.02% | 42.97% | |
52 Neutral | HK$3.48B | 4.89 | 7.19% | 6.05% | -21.80% | -8.00% |